Literature DB >> 25853590

Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era.

Sushma K Cribbs1, Caroline Tse, Joel Andrews, Neeta Shenvi, Greg S Martin.   

Abstract

OBJECTIVES: Although highly active antiretroviral therapy has led to improved survival in HIV-infected individuals, outcomes for HIV-infected patients with sepsis in the post-highly active antiretroviral therapy era are conflicting. Access to highly active antiretroviral therapy and healthcare disparities continue to affect outcomes. We hypothesized that HIV-infected patients with severe sepsis would have worse outcomes compared with their HIV-uninfected counterparts in a large safety-net hospital where access to healthcare is low and delivery of critical care is delayed.
DESIGN: Secondary analysis of an ongoing prospective observational study between 2006 and 2010.
SETTING: Three adult ICUs (medical ICU, surgical ICU, and neurologic ICU) at Grady Memorial Hospital, Atlanta, GA. PATIENTS: Adult patients with severe sepsis in the ICU.
INTERVENTIONS: Baseline patient characteristics and clinical outcomes were collected. HIV-infected and HIV-uninfected patients with sepsis were compared using t tests, chi-square tests, and logistic regression; p values less than 0.05 indicated significance.
MEASUREMENTS AND MAIN RESULTS: Of 1,095 patients with severe sepsis enrolled, 165 (15%) were positive for HIV, with a median CD4 count of 41 (8-167). Twenty-two percent of HIV-infected patients were on highly active antiretroviral therapy prior to admission, and 80% had a CD4 count less than 200. HIV-infected patients had a greater hospital mortality (50% vs 38%; p < 0.01). HIV infection (odds ratio = 1.78; p = 0.005) was an independent predictor of mortality by multivariate regression modeling after adjusting for age, history of pneumonia, history of hospital-acquired infection, and history of sepsis.
CONCLUSIONS: HIV-infected patients with severe sepsis continue to suffer worse outcomes compared with HIV-uninfected patients in a large urban safety-net hospital caring for patients with limited access to medical care. Further studies need to be done to investigate the effect of socioeconomic status and mitigate healthcare disparities among critically ill HIV-infected patients.

Entities:  

Mesh:

Year:  2015        PMID: 25853590     DOI: 10.1097/CCM.0000000000001003

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  HIV Infection and Severe Sepsis: A Bitter Pill to Swallow.

Authors:  Matthew R Gingo; Alison Morris
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

2.  Health Disparities and Sepsis: a Systematic Review and Meta-Analysis on the Influence of Race on Sepsis-Related Mortality.

Authors:  Panagis Galiatsatos; Junfeng Sun; Judith Welsh; Anthony Suffredini
Journal:  J Racial Ethn Health Disparities       Date:  2019-05-29

3.  Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis.

Authors:  Wilian Correa-Macedo; Vinicius M Fava; Marianna Orlova; Pauline Cassart; Ron Olivenstein; Joaquín Sanz; Yong Zhong Xu; Anne Dumaine; Renata Hm Sindeaux; Vania Yotova; Alain Pacis; Josée Girouard; Barbara Kalsdorf; Christoph Lange; Jean-Pierre Routy; Luis B Barreiro; Erwin Schurr
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

4.  Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study.

Authors:  Maryse A Wiewel; Michaëla A Huson; Lonneke A van Vught; Arie J Hoogendijk; Peter M C Klein Klouwenberg; Janneke Horn; René Lutter; Olaf L Cremer; Marcus J Schultz; Marc J Bonten; Tom van der Poll
Journal:  Crit Care       Date:  2016-10-10       Impact factor: 9.097

Review 5.  Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and meta-analysis.

Authors:  Hugo Boechat Andrade; Cassia Righy Shinotsuka; Ivan Rocha Ferreira da Silva; Camila Sunaitis Donini; Ho Yeh Li; Frederico Bruzzi de Carvalho; Pedro Emmanuel Alvarenga Americano do Brasil; Fernando Augusto Bozza; Andre Miguel Japiassu
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

6.  Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy.

Authors:  Shannon L Turvey; Sean M Bagshaw; Dean T Eurich; Wendy I Sligl
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-02-27       Impact factor: 2.471

7.  A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis.

Authors:  Sabrina Sabino; Silvia Soares; Fabiano Ramos; Miriane Moretti; Alexandre P Zavascki; Maria Helena Rigatto
Journal:  mSphere       Date:  2019-04-10       Impact factor: 4.389

Review 8.  Management of HIV-infected patients in the intensive care unit.

Authors:  François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.